The exercise period for warrants of series TO 4 begins today
Today, on October 20th, 2021, the exercise period begins for warrants of series TO 4 in Smoltek Nanotech Holding AB (publ) (“Smoltek” or the “Company”). The exercise period runs until November 3rd, 2021. Each warrant of series TO 4 entitles the holder to subscribe for one (1) new share in the Company at a price of SEK 18.82 per share. If all warrants of series TO 4 are exercised, the Company will receive approximately SEK 23.7 million before issue costs. In order for the warrants not to expire without value, it is required that the holder subscribes for shares no later than November 3rd, 2021, or alternatively sells the warrants no later than November 1st, 2021.
Letters to warrant holders of series TO 4 are available from the Company's website at www.smoltek.com/toptions-to4.
Full terms and conditions for the warrants and application form are also available at the above web address.
Summarized terms for the warrants of series TO 4:
Exercise period: October 20th, 2021 – November 3rd, 2021.
Exercise price: SEK 18.82 per share.
Issue size: 1 261 121 warrants of series TO 4. If all the warrants are exercised, 1 261 121 shares are issued, and the Company will receive approximately SEK 23.7 million before issuing costs.
Last day for trading with warrants of series TO 4: November 1st, 2021.
Note that the warrants that are not exercised at latest on November 3rd, 2021, or sold at the latest on November 1st, 2021, will expire without value. For the warrants not to lose their value, the holder must actively subscribe for new shares or sell the warrants. Please observe that certain nominees might close their application earlier than November 3rd 2021.
Full terms an conditions for the warrants are available at the Company's website, www.smoltek.com/investors, and Mangold’s website, www.mangold.se.
How to excersice the warrants:
Nominee-registered warrants (custody):
Subscription and payment through the exercise of the warrants shall take place in accordance with instructions from the respective nominee. Please contact your nominee for further information.
Directly registered warrants (VP account):
No issue report or payment instruction will be sent out. Subscription must be made by simultaneous cash payment according to the instructions on the application form. The warrants are then replaced with interim shares (IA) pending registration at the Swedish Companies Registration Office.
The application form with instructions for payment will be available on the Company's website, www.smoltek.com/investors, and on the issue institute Mangold Fondkommission AB's website, www.mangold.se.
Advisers
Mangold Fondkommission AB is financial adviser and issuing agent and MAQS Advokatbyrå AB is legal advisor to Smoltek in connection with the exercise of the warrants of series TO 4.
For questions regarding the warrants, please contact:
Mangold Fondkommission AB
Tel: +46 8 5030 1595
E-mail: emissioner@mangold.se
For more information regarding Smoltek, please contact:
Håkan Persson, CEO of Smoltek Nanotech Holding AB (publ)
Phone: +46 760 52 00 53
E-mail: info@smoltek.com
Website: www.smoltek.com/investors
Smoltek develops process technology and concepts for applications based on carbon nanotechnology to solve advanced materials engineering problems in several industrial sectors. The company protects its unique technology through an extensive and expanding patent portfolio consisting of around 100 applied for patents, of which today 69 have been granted. Smoltek's share is listed on the Spotlight Stock Market in Stockholm, Sweden under the ticker SMOL. Smoltek is a development company, and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.